Dual use of antifungals in medicine and agriculture: How do we help prevent resistance developing in human pathogens?

Paul E Verweij; Maiken C Arendrup; Ana Alastruey-Izquierdo; Jeremy A W Gold; Shawn R Lockhart; Tom Chiller; P Lewis White

doi:10.1016/j.drup.2022.100885

Dual use of antifungals in medicine and agriculture: How do we help prevent resistance developing in human pathogens?

Paul E Verweij^*
, Maiken C Arendrup
, Ana Alastruey-Izquierdo
, Jeremy A W Gold
, Shawn R Lockhart
, Tom Chiller
, P Lewis White

^*Corresponding author af dette arbejde

Afdeling for Klinisk Mikrobiologi

56 Citationer (Scopus)

Abstract

Azole resistance in Aspergillus fumigatus is a One Health resistance threat, where azole fungicide exposure compromises the efficacy of medical azoles. The use of the recently authorized fungicide ipflufenoquin, which shares its mode-of-action with a new antifungal olorofim, underscores the need for risk assessment for dual use of antifungals.

Originalsprog	Engelsk
Artikelnummer	100885
Tidsskrift	Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Vol/bind	65
Sider (fra-til)	1-4
Antal sider	4
ISSN	1368-7646
DOI	https://doi.org/10.1016/j.drup.2022.100885
Status	Udgivet - dec. 2022

Adgang til dokumentet

10.1016/j.drup.2022.100885

Andre filer og links

Link to publication in Scopus

Citationsformater

Verweij, P. E., Arendrup, M. C., Alastruey-Izquierdo, A., Gold, J. A. W., Lockhart, S. R., Chiller, T., & White, P. L. (2022). Dual use of antifungals in medicine and agriculture: How do we help prevent resistance developing in human pathogens? Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 65, 1-4. Artikel 100885. https://doi.org/10.1016/j.drup.2022.100885

Dual use of antifungals in medicine and agriculture: How do we help prevent resistance developing in human pathogens? / Verweij, Paul E; Arendrup, Maiken C; Alastruey-Izquierdo, Ana et al.
I: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, Bind 65, 100885, 12.2022, s. 1-4.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Verweij, PE, Arendrup, MC, Alastruey-Izquierdo, A, Gold, JAW, Lockhart, SR, Chiller, T & White, PL 2022, 'Dual use of antifungals in medicine and agriculture: How do we help prevent resistance developing in human pathogens?', Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, bind 65, 100885, s. 1-4. https://doi.org/10.1016/j.drup.2022.100885

@article{1deb48a62b8b4f6fb3dcace5bbd37f2b,

title = "Dual use of antifungals in medicine and agriculture: How do we help prevent resistance developing in human pathogens?",

abstract = "Azole resistance in Aspergillus fumigatus is a One Health resistance threat, where azole fungicide exposure compromises the efficacy of medical azoles. The use of the recently authorized fungicide ipflufenoquin, which shares its mode-of-action with a new antifungal olorofim, underscores the need for risk assessment for dual use of antifungals.",

keywords = "Aspergillus fumigatus, DHODH inhibitor, One Health, triazole resistance, olorofim",

author = "Verweij, \{Paul E\} and Arendrup, \{Maiken C\} and Ana Alastruey-Izquierdo and Gold, \{Jeremy A W\} and Lockhart, \{Shawn R\} and Tom Chiller and White, \{P Lewis\}",

year = "2022",

month = dec,

doi = "10.1016/j.drup.2022.100885",

language = "English",

volume = "65",

pages = "1--4",

journal = "Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy",

issn = "1368-7646",

publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - Dual use of antifungals in medicine and agriculture

T2 - How do we help prevent resistance developing in human pathogens?

AU - Verweij, Paul E

AU - Arendrup, Maiken C

AU - Alastruey-Izquierdo, Ana

AU - Gold, Jeremy A W

AU - Lockhart, Shawn R

AU - Chiller, Tom

AU - White, P Lewis

PY - 2022/12

Y1 - 2022/12

N2 - Azole resistance in Aspergillus fumigatus is a One Health resistance threat, where azole fungicide exposure compromises the efficacy of medical azoles. The use of the recently authorized fungicide ipflufenoquin, which shares its mode-of-action with a new antifungal olorofim, underscores the need for risk assessment for dual use of antifungals.

AB - Azole resistance in Aspergillus fumigatus is a One Health resistance threat, where azole fungicide exposure compromises the efficacy of medical azoles. The use of the recently authorized fungicide ipflufenoquin, which shares its mode-of-action with a new antifungal olorofim, underscores the need for risk assessment for dual use of antifungals.

KW - Aspergillus fumigatus

KW - DHODH inhibitor

KW - One Health

KW - triazole resistance

KW - olorofim

UR - https://www.scopus.com/pages/publications/85140326308

U2 - 10.1016/j.drup.2022.100885

DO - 10.1016/j.drup.2022.100885

M3 - Journal article

C2 - 36283187

SN - 1368-7646

VL - 65

SP - 1

EP - 4

JO - Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

JF - Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

M1 - 100885

ER -

Dual use of antifungals in medicine and agriculture: How do we help prevent resistance developing in human pathogens?

Abstract

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater